0001594864-16-000002.txt : 20160706 0001594864-16-000002.hdr.sgml : 20160706 20160705180837 ACCESSION NUMBER: 0001594864-16-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20160706 DATE AS OF CHANGE: 20160705 EFFECTIVENESS DATE: 20160706 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Juno Therapeutics, Inc. CENTRAL INDEX KEY: 0001594864 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 463656275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-243722 FILM NUMBER: 161751871 BUSINESS ADDRESS: STREET 1: 307 WESTLAKE AVENUE NORTH, SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 2066960703 MAIL ADDRESS: STREET 1: 307 WESTLAKE AVENUE NORTH, SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98109 D/A 1 primary_doc.xml X0707 D/A LIVE 0001594864 Juno Therapeutics, Inc. 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA WASHINGTON 98109 (206) 582-1600 DELAWARE FC Therapeutics, Inc. None Corporation true 2013 Hans Bishop 307 Westlake Avenue North, Suite 300 Seattle WA WASHINGTON 98109 Executive Officer Director Promoter Steven Harr 307 Westlake Avenue North, Suite 300 Seattle WA WASHINGTON 98109 Executive Officer Robert Azelby 307 Westlake Avenue North, Suite 300 Seattle WA WASHINGTON 98109 Executive Officer Hyam Levitsky 307 Westlake Avenue North, Suite 300 Seattle WA WASHINGTON 98109 Executive Officer Bernard J. Cassidy 307 Westlake Avenue North, Suite 300 Seattle WA WASHINGTON 98109 Executive Officer Hal Barron 307 Westlake Avenue North, Suite 300 Seattle WA WASHINGTON 98109 Director Anthony Evnin 307 Westlake Avenue North, Suite 300 Seattle WA WASHINGTON 98109 Director Richard Klausner 307 Westlake Avenue North, Suite 300 Seattle WA WASHINGTON 98109 Director Promoter Robert Nelsen 307 Westlake Avenue North, Suite 300 Seattle WA WASHINGTON 98109 Director Promoter Howard Pien 307 Westlake Avenue North, Suite 300 Seattle WA WASHINGTON 98109 Director Marc Tessier-Lavigne 307 Westlake Avenue North, Suite 300 Seattle WA WASHINGTON 98109 Director Mary Agnes Wilderotter 307 Westlake Avenue North, Suite 300 Seattle WA WASHINGTON 98109 Director Thomas Daniel 307 Westlake Avenue North, Suite 300 Seattle WA WASHINGTON 98109 Director Biotechnology $5,000,001 - $25,000,000 06c true 0001594864-15-000001 2015-06-29 true true true true false 0 Indefinite 896803493 Indefinite See the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on June 29, 2015 and March 28, 2016. false 2 0 0 0 false Juno Therapeutics, Inc. /s/ Bernard J. Cassidy Bernard J. Cassidy General Counsel & Secretary 2016-07-05